| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/28/2001 | CA2394222A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | CA2393018A1 A stable immunogenic composition for frozen storage |
| 06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1110550A2 Composition comprising ascorbic acid and pectin |
| 06/27/2001 | EP1110545A2 Pharmaceutical preparations for the targeted treatment of Morbus Crohn and Colitis Ulcerosa |
| 06/27/2001 | EP1110544A2 Use of a film coating as taste masking coating for oral dosage forms |
| 06/27/2001 | EP1110543A2 Extended release oral dosage composition |
| 06/27/2001 | EP1110542A2 Once-a-day metoprolol oral dosage form |
| 06/27/2001 | EP1110541A1 Controlled release composition comprising a sustained release layer and a fast release layer |
| 06/27/2001 | EP1110462A2 Encapsulated multifunctional, biologically active food ingredient, process for its manufacture and use thereof |
| 06/27/2001 | EP1109926A1 Condensed plasmid-liposome complex for transfection |
| 06/27/2001 | EP1109900A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 06/27/2001 | EP1109896A1 Adenovirus formulations for gene therapy |
| 06/27/2001 | EP1109871A1 Coating of solid surfaces with activated polyhydroxypolymers |
| 06/27/2001 | EP1109838A1 Redispersible powder and its aqueous dispersion, preparation process and use |
| 06/27/2001 | EP1109837A1 Method for producing ultra-pure alginates |
| 06/27/2001 | EP1109832A1 Ozf protein-specific monoclonal antibodies and their diagnostic therapeutic uses |
| 06/27/2001 | EP1109806A1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates |
| 06/27/2001 | EP1109581A1 Preserved cyclodextrin-containing compositions |
| 06/27/2001 | EP1109578A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
| 06/27/2001 | EP1109576A2 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 06/27/2001 | EP1109563A2 End modified thermal responsive hydrogels |
| 06/27/2001 | EP1109558A2 Sustained release ranolazine formulations |
| 06/27/2001 | EP1109551A1 4-amino-3-mercapto-1,2,4-triazoles |
| 06/27/2001 | EP1109539A1 Nanogel networks and biological agent composition thereof |
| 06/27/2001 | EP1109537A1 Immediate release tablet |
| 06/27/2001 | EP1109536A1 New solid dose form of nanoparticulate naproxen |
| 06/27/2001 | EP1109534A1 Quick release pharmaceutical compositions of drug substances |
| 06/27/2001 | EP1109533A1 Pulmonary delivery of liposome-encapsulated cannabinoids |
| 06/27/2001 | EP1109532A1 Oral micro-emulsion composition of silybin |
| 06/27/2001 | EP1109529A1 Lipid extract of the skeletonema algae |
| 06/27/2001 | EP1109526A1 Improved stability for injection solutions |
| 06/27/2001 | EP1109447A2 Prolonged storage of red blood cells |
| 06/27/2001 | EP0909158A4 Aqueous product comprising oil microdroplets stabilized by in-situ polymerized vinyl monomer and a thickening agent |
| 06/27/2001 | EP0820473B1 Biodegradable polyacetal polymers and formation and use |
| 06/27/2001 | EP0792167B1 Monofunctional and/or polyfunctional polylysine conjugates |
| 06/27/2001 | EP0767669B1 New pharmaceutical preparation for pain management |
| 06/27/2001 | EP0743854B1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production |
| 06/27/2001 | EP0730869B1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 06/27/2001 | EP0727979B1 Novel composition |
| 06/27/2001 | EP0676962B1 Enhanced pharmaceutical compositions for skin penetration for piroxicam |
| 06/27/2001 | EP0577648B1 Novel protein polycation conjugates |
| 06/27/2001 | CN1301182A Solid preparations for oral administration of drugs relating to genes |
| 06/27/2001 | CN1301179A Hemoglobin-polysaccharide conjugates |
| 06/27/2001 | CN1301178A Solution comprising prostaglandins and benzyl alcohol |
| 06/27/2001 | CN1301176A Use of active P40 conjugates for nasal delivery |
| 06/27/2001 | CN1301171A Cyclosporin preparations |
| 06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 06/27/2001 | CN1301163A Controlled release peroral compositions of levosimendan |
| 06/27/2001 | CN1301157A Sustained release preparations |
| 06/27/2001 | CN1301155A Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative process for preparing the same |
| 06/27/2001 | CN1301152A Transdermal therapeutic system containing pergolide |
| 06/27/2001 | CN1301151A Regulated release preparations |
| 06/27/2001 | CN1301150A Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 06/27/2001 | CN1301149A Delavirdine tablet formulation |
| 06/27/2001 | CN1301148A Pharmaceutical preparation containing levothyroxine sodium |
| 06/27/2001 | CN1301147A Pharmaceutical compositions capable of being gelled |
| 06/27/2001 | CN1301146A Topical hormonal composition with systemic effect |
| 06/27/2001 | CN1301136A Use of liquid carbohydrate fermentation product in foods |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300733A Comptothecin compounds and preparation thereof |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1300562A Composition containing fat-soluble vitamins |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251945 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 06/26/2001 | US6251941 Use of inhaled retinoids in the prevention of cancer |
| 06/26/2001 | US6251920 Administering tamoxifen or its structural analogs for prophylaxis and therapy of atherosclerosis, thrombosis, myocardial infarction and stroke |
| 06/26/2001 | US6251884 Pharmacologically acceptable composition for inhibiting or treating liver disease or inflammatory condition of gastrointestinal tract in mammal, comprising sulfate of ursodeoxycholic acid or salt thereof, carrier |
| 06/26/2001 | US6251879 Reducing wool fiber diameter in wool producing animal by administering effective amount of antimethanogenic agent for time and under conditions sufficient to allow wool growth |
| 06/26/2001 | US6251869 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 06/26/2001 | US6251866 A water soluble, biocompatible polymer, a chemical agent covalently, releasably coupled to the polymer and an interleukin-2-receptor binding peptide of given sequence covalently coupled to the polymer |
| 06/26/2001 | US6251859 Deepithelialized skin diffusion cell system |
| 06/26/2001 | US6251858 Derivatives of glycosylamine in which the oligosides are fixed on at least one molecule, matrix or particle |
| 06/26/2001 | US6251857 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/26/2001 | US6251678 Mixture of virus particles, salt, histidine buffer and nonionic surfactant |
| 06/26/2001 | US6251599 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 06/26/2001 | US6251446 Fermenting xanthomonas bacterium in carbohydrate medium other than dairy whey to yield liquid fermentation broth product which is a hydrocolloid-containing thickening agent and directly adding, without concentrating, or drying to food |
| 06/26/2001 | US6251436 Drug preparations for treating sexual dysfunction |
| 06/26/2001 | US6251434 Preparations of non-steroidal analgesics |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251432 Sustained release dosage form unit having latex coating and method of making the same |
| 06/26/2001 | US6251428 Preparation of aqueous clear solution dosage forms with bile acids |
| 06/26/2001 | US6251426 Ibuprofen-containing softgels |
| 06/26/2001 | US6251425 Glucoside paucilamellar vesicles |
| 06/26/2001 | US6251423 Bandages and dressings |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251401 Comprising haemophilus influenzae type b and neisseria meningitidis serotype c capsular oligosaccharide conjugates, where the oligosaccharides are size-selected to exclude short chain oligosaccharides |
| 06/26/2001 | US6251394 Method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 06/26/2001 | US6251392 Polypeptides for cell targets |
| 06/26/2001 | US6251382 Biodegradable high molecular weight polymeric linkers and their conjugates |
| 06/26/2001 | US6251371 Treatment of skin or mucosa inflammation by topical treatment with preparation containing dichlorobenzyl alcohol |
| 06/26/2001 | US6251368 Aerosol drugs salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts |
| 06/26/2001 | US6250469 Formulations for protection of peg-interferon alpha conjugates |
| 06/26/2001 | CA2278133C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/23/2001 | CA2329574A1 Controlled release composition |
| 06/21/2001 | WO2001044808A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044441A1 Stabilizing diluent for polypeptides and antigens |